-"People must support Treatment Action Campaign (TAC) because the government is dragging its feet for four years. It is no good for me to be on anti-retroviral drugs and my friends on the ground are dying."
The Geneva-based Global Fund to Fight AIDS has just granted 92 million U.S. Dollars to Cote D'Ivoire to fight AIDS in the strife-torn West African country.
The increasing incidence of hepatitis and fears of an HIV breakout forced the Pakistani government to finally formulate this month a framework to ensure blood screening, but public health experts say it suffers from major flaws.
With medical bills constantly shooting up, people living with HIV/AIDS in Gabon are increasingly turning to traditional healers for treatment.
Charges of culpable homicide have been laid against the South African minister of health, Manto Tshabala-Msimang, and the minister of trade and industry, Alec Erwin, by the Treatment Action Campaign (TAC) - an organisation demanding the provision of anti-AIDS drugs to poor people living with the disease.
The Treatment Action Campaign (TAC), a lobby group fighting to get the South African government to make anti-HIV/AIDS drugs, like anti-retrovirals, freely available in the public health system, is getting ready to launch a civil disobedience campaign in support of their demands.
Agnes Thom Mavhuto, 68, wonders why women should ever celebrate the International Women's Day every year.
Population and women's reproductive-health groups are calling on U.S. President George W. Bush not to impose strict, anti-abortion conditions on his five-year, 15-billion-dollar plans to fight HIV-AIDS in Africa and the Caribbean.
Government and the AIDS movement are heading for another winter of discontent in South Africa as attempts to forge a national deal on HIV/AIDS prevention and treatment fell apart at the weekend.
''Prostitution, resulting from extreme poverty, is increasing the risk of HIV/AIDS infection among displaced persons in Cote d'Ivoire,'' according to the UN Children's Fund (UNICEF).
French scientists claim at least partial success in developing a vaccine against HIV.
Twenty-two countries that ended a mini-summit Sunday on trade liberalisation, including the touchy issues of agricultural subsidies and access to cheaper drugs, reached no breakthrough here - and managed only an agreement to discuss the matter further.
Mutabazi Enos, 33, is a proud man. He was among the 40 Ugandans who volunteered for the first HIV/AIDS vaccine trials in 1999.